Silicon Laboratories Reports 18.3% Revenue Growth to $228.2 Million in Q2 2026

Silicon Laboratories Inc. reported a significant increase in financial performance for the second quarter of fiscal 2026, with revenues reaching $228.2 million, up 18.3% from $192.8 million in the same period last year. The company's gross profit also rose to $140.7 million, reflecting a gross margin of 61.6%, compared to 56.1% in the prior year. This improvement in profitability was attributed to increased sales in both the Industrial & Commercial and Home & Life product categories, which saw revenue increases of 23.0% and 12.2%, respectively.

Despite the revenue growth, Silicon Laboratories experienced an operating loss of $10.7 million for the quarter, an improvement from the $22.9 million loss reported in the same quarter of the previous year. The increase in operating expenses, which totaled $151.3 million, was primarily driven by higher personnel-related costs and expenses associated with the company's proposed merger with Texas Instruments. The net loss for the quarter was $10.6 million, or $(0.32) per share, compared to a net loss of $21.8 million, or $(0.67) per share, in the prior year.

The company is in the process of merging with Texas Instruments, a move that was announced in February 2026 and has received board and stockholder approval. The merger is expected to close in the first half of 2027, pending regulatory approvals. In connection with this merger, Silicon Laboratories incurred $9.6 million in costs during the quarter and anticipates further expenses related to financial advisory, legal, and accounting services.

Operationally, Silicon Laboratories reported an increase in accounts receivable to $79.8 million, reflecting a days sales outstanding (DSO) of 31 days. Inventory levels also rose to $123.3 million, representing 127 days of inventory (DOI). The company noted that 90% of its revenues were derived from international markets, with no single customer accounting for more than 10% of total revenues during the six-month period ending July 4, 2026.

Looking ahead, Silicon Laboratories remains cautious due to macroeconomic conditions, including inflationary pressures and geopolitical tensions that could impact demand for its products. The company believes its existing cash, cash equivalents, and short-term investments, totaling $397.2 million, along with its credit facility, will be sufficient to meet its capital requirements over the next twelve months. However, it may seek additional funding for future acquisitions or strategic initiatives.